Levetiractam in the treatment of two children with myoclonic status epilepticus

European Journal of Paediatric Neurology

Volumn 13, Issue 6, 2009, Pages 546-549

  Haberlandt, E ^a   Sigl, S Baumgartner ^a   Scholl Buergi, S ^a   Karall, D ^a   Rauchenzauner, M ^a   Rostasy K ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Children; Intravenous; Levetiracetam; Myoclonic status epilepticus

Indexed keywords

CLOBAZAM; DEXAMETHASONE; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; LAMOTRIGINE; LORAZEPAM; PHENOBARBITAL; PYRIDOXINE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

ABSENCE OF SIDE EFFECTS; ARTICLE; CASE REPORT; CHILD; COGNITION; DRUG BLOOD LEVEL; DRUG RESPONSE; DRUG SAFETY; ELECTROENCEPHALOGRAPHY; EPILEPTIC STATE; HUMAN; INFANT; MAINTENANCE DRUG DOSE; MALE; MOTOR PERFORMANCE; MYOCLONUS EPILEPSY; PRESCHOOL CHILD; PRIORITY JOURNAL; SLOW BRAIN WAVE; SPIKE WAVE; TREATMENT DURATION;

ANTICONVULSANTS; CHILD; ELECTROENCEPHALOGRAPHY; HUMANS; INFANT; MALE; PIRACETAM; STATUS EPILEPTICUS;

EID: 70350571359     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2008.09.006     Document Type: Article

References (23)

1. Eriksson K., and Kalviainien R. Pharmacological management of convulsive status epilepticus in childhood. Expert Rev Neurother 5 (2005) 777-783
2. Kaplan P.W. Assessing the outcomes in patients with nonconvulsive status epilepticus: nonconvulsive status epilepticus is underdiagnosed, potentially overtreated, and confounded by comorbidity. J Clin Neurophysiol 16 4 (1999) 341-352
3. Shorvon S.D., and van Rijckevorsel K. A new antiepileptic drug. J Neurol Neurosurg Psychiatry 72 4 (2002) 426-429
4. Lynch B.A., Lambeng N., Nocka K., Kensel-Hammes P., Bajjalieh S.M., Matagne A., et al. The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam. Proc Natl Acad Sci U S A 101 26 (2004) 9861-9866
5. 2+]I increase induced by ATP and bradykinin in PC12 cells. J Pharmacol Exp Ther 313 2 (2005) 720-730
6. Madeja M., Margineanu D.G., Gorji A., Siep E., Boerrigter P., Klitgaard H., et al. Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?. Neuropharmacology 45 5 (2003) 661-671
7. De Los Reyes E.C., Sharp G.B., Williams J.P., and Hale S.E. Levetiracetam in the treatment of Lennox-Gastaut syndrome. Pediatr Neurol 30 4 (2004) 254-256
8. Glauser T.A., and Dulac O. Preliminary efficacy of levetiracetam in children. Epileptic Disord 5 Suppl. 1 (2003) 45-50
9. Patel N.C., Landan I.R., Levin J., Szaflarski J., and Wilner A.N. The use of levetiracetam in refractory status epilepticus. Seizure 15 3 (2006) 137-141
10. Ramael S., Daoust A., Otoul C., Toublanc N., Troenaru M., Lu Z.S., et al. Levetiracetam intravenous infusion: a randomized, placebo-controlled safety and pharmacokinetic study. Epilepsia 47 7 (2006) 1128-1135
11. Genton P., and Dravet C. Treatment of epilepsies with myoclonias. In: Shorvon S., Dreifuss F., Fish D., and Thomas D. (Eds). The treatment of epilepsy (1996), Blackwell Science, London 247-257
12. Genton P., Guerrini R., and Remi C. Piracetam in the treatment of cortical myoclonus. Pharmacopsychiatry 32 Suppl. 1 (1999) 49-53
13. Genton P., and Van Vleymen B. Piracetam and levetiracetam: close structural similarities but different pharmacological and clinical profiles. Epileptic Disord 2 2 (2000) 99-105
14. French J., and Arrigo C. Rapid onset of action of levetiracetam in refractory epilepsy patients. Epilepsia 46 2 (2005) 324-326
15. Di Bonaventura C., Fattouch J., Mari F., Egeo G., Vaudano A.E., Prencipe M., et al. Clinical experience with levetiracetam in idiopathic generalized epilepsy according to different syndrome subtypes. Epileptic Disord 7 3 (2005) 231-235
16. Gelisse P., Crespel A., Genton P., and Baldy-Moulnier M. Dramatic effect of levetiracetam on epileptic negative myoclonus. Acta Neurol Scand 107 4 (2003) 302-303
17. Genton P., and Gelisse P. Antimyoclonic effect of levetiracetam. Epileptic Disord 2 4 (2000) 209-212
18. Genton P., and Gelisse P. Suppression of post-hypoxic and post-encephalitic myoclonus with levetiracetam. Neurology 57 6 (2001) 1144-1145
19. Pinol G., Khurana D.S., Legido A., Kothare S.V., Marks H., Hardison H.H., et al. Efficacy of levetiracetam in myoclonic seizures in children with symptomatic generalized epilepsy. Epilepsia 47 Suppl. 4 (2006) 2197
20. Striano P., Mancardi M.M., Coppola A., Baglietto M.G., Striano S., Zara F., et al. Efficacy and tolerability of levetiracetam in severe myoclonic epilepsy of infancy (Dravet Syndrome): a pilot study. Epilepsia Suppl. 4 (2006) 2195
21. Trabacca A., Profice P., Costanza M., Gesualda M., and Rinaldis M. Levetiracetam in nonconvulsive status epilepticus in childhood: a case report. J Child Neurol 22 5 (2007) 639-641
22. Kroll-Seger, Mothersill I.W., Novak S., Salke-Kellermann R.A., and Kramer G. Levetiracetam-induced myoclonic status epilepticus in myoclonic-astatic epilepsy: a case report. Epileptic Disord 8 3 (2006) 213-218
23. Atefy R., and Tettenborn B. Nonconvulsive status epilepticus on treatment with levetiracetam. Epilepsy Behav 6 4 (2005) 613-616